SCHEMBL21363636

SCHEMBL21363636

C=C(C)c1cc2c(cc1OCc1ccccc1)OCO2

nearest known ligand 0.59

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAOB P27338 8/20 0.59
MAOA P21397 5/20 0.49
NPC1 O15118 3/20 0.47
RAB9A P51151 3/20 0.47
KMT2A Q03164 2/20 0.46
TDP1 Q9NUW8 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
TSHR P16473 3/20 0.44
ALDH1A1 P00352 2/20 0.44
TP53 P04637 1/20 0.44
MAPT P10636 1/20 0.44
ATM Q13315 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
CYP3A4 P08684 1/20 0.43
KDM4E B2RXH2 2/20 0.42
HSD17B10 Q99714 1/20 0.42
HTT P42858 1/20 0.42
EDNRB P24530 2/20 0.41
EDNRA P25101 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10565899 0.86 MAOB (0.56) MAOBMAOANPC1RAB9AKMT2A
SCHEMBL1316052 0.83 MAOB (0.58) MAOBMAOANPC1RAB9AKMT2A
SCHEMBL21363607 0.83 MAOB (0.51) MAOBMAOANPC1RAB9AKMT2A
SCHEMBL9789582 0.79 KMT2A (0.51) MAOBMAOANPC1RAB9AKMT2A
SCHEMBL7775193 0.79 MAOB (0.59) MAOBMAOANPC1RAB9AKMT2A
SCHEMBL13854257 0.79 MAOB (0.59) MAOBMAOANPC1RAB9AKMT2A
SCHEMBL21363783 0.77 MAOB (0.51) MAOBMAOANPC1RAB9AKMT2A
SCHEMBL21366597 0.77 MAOB (0.57) MAOBMAOANPC1RAB9AKMT2A
SCHEMBL6918873 0.77 RXRA (0.45) MAOBKMT2ATDP1L3MBTL1MAPT
SCHEMBL14365267 0.76 SMN1; SMN2 (0.47) MAOBNPC1RAB9AKMT2ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019175712-A1 NEW USES FOR CATECHOL MOLECULES AS INHIBITORS TO GLUTATHIONE S-TRANSFERASE METABOLIC PATHWAYS BASF CORPORATION (US) 2019-09-19 WO disclosed
WO-2019175713-A1 NEW CATECHOL MOLECULES AND THEIR USE AS INHIBITORS TO P450 RELATED METABOLIC PATHWAYS BASF CORPORATION (US) 2019-09-19 WO disclosed